Condition: Heart Failure · Sponsor: Occlutech International AB
This study aims to monitor the safety and efficacy of Occlutech AFR device in patients with Heart Failure.
This description comes directly from the study's public registry record.
Gönül Sonmez Utkun · +90 542 826 11 95 · dl_occlutech_clinical_team_eu-ist@occlutech.com
Sankoung Minte · +337 68 20 44 58 · sankoung.minte@keena-lifesciences.com
Always discuss trial participation with your own doctor first.
| CHU Besançon | Besançon, France | Recruiting |
| CHU Bourdeaux | Bourdeaux, France | Recruiting |
| CHU Lyon | Lyon, France | Recruiting |
| CHU Montpellier | Montpellier, France | Recruiting |
| Centre Hospitalier Universitaire Rangueil | Toulouse, France | Not Yet Recruiting |
| Knappschaftskrankenhaus Bottrop GmbH | Bottrop, Germany | Not Yet Recruiting |
| Clinic Coburg | Coburg, Germany | Recruiting |
| University Clinic | Cologne, Germany | Recruiting |
| Helios Clinic Erfurt | Erfurt, Germany | Active Not Recruiting |
| Cardiologicum Hamburg | Hamburg, Germany | Terminated |
| WKK Heide | Heide, Germany | Recruiting |
| University Clinic Jena | Jena, Germany | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04405583